Article Details

NeoImmuneTech Announces First Patient Dosed in the Pilot Study of NT-I7 (efineptakin alfa) in ...

Retrieved on: 2021-05-24 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

NeoImmuneTech Announces First Patient Dosed in the Pilot Study of NT-I7 (efineptakin alfa) in .... View article details on hiswai:

Excerpt

... NT-I7 is an ideal candidate to bolster patients' immune response and help ... of immuno-oncology and enhancing immunity to infectious diseases.

Article found on: www.galvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up